In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...

Peptide Based Cancer Therapeutics Market Expected to Reach USD 17.18 Billion by 2027, Registering a CAGR of 9.1% The global peptide based cancer therapeutics market was valued at USD 8.58 billion in 2019 and is expected to grow at a CAGR of 9.1% during the 2020–2027 forecast period, according to Polaris Market Research. The market is projected to reach USD 17.18 billion by 2027....

How large can a drug class get once it proves it can treat obesity, diabetes and heart risk at the same time? The peptide therapeutics market offers an early answer. Valued at USD 140.9 billion in 2025, it is projected to reach USD 294.6 billion by 2033, growing at 8.7% annually from 2026. North America accounts for 61.9% of today’s revenue, but the factors that decide the next USD 130...

Peptide Therapeutics Market Outlook: Straits Research, a leading provider of business intelligence, research, analytics, and advisory services, has published its latest report on the global peptide therapeutics market. The report highlights steady growth driven by advancements in drug development, increasing prevalence of chronic diseases, and rising demand for targeted and personalized...

The global peptide therapeutics market is experiencing strong growth, driven by increasing demand for targeted treatments, rising prevalence of chronic diseases, and advancements in peptide-based drug development. Peptide therapeutics are increasingly used to treat metabolic disorders, cancer, cardiovascular conditions, neurological disorders, and other diseases. Their ability to interact...

Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...